about
5-Lipoxygenase activity in the human pancreasIsolation and properties of platelet-activating factor receptor cDNAsPlatelet-activating factor (PAF) antagonistic actions of two new analogs of tetrahydrofuransRP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF releaseInvolvement of platelet-activating factor in the hypotensive response to zymosan in rats.Cardiopulmonary and intravascular alterations during the sustained infusion of PAF.Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity.Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation.Characterization of platelet-activating factor induced superoxide anion generation by guinea-pig alveolar macrophages.Formation of PAF-like compounds by peroxidation of phospholipids from bovine brain.Is platelet-activating factor involved in bronchopulmonary hyperresponsiveness?Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock.Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms.The nuclear receptors of retinoic acid.Growth factors, lipid mediators and effector cells.Brief review: molecular mechanisms of neutrophil binding to endothelium involving platelet-activating factor and cytokines.New trends in mammalian non-pancreatic phospholipase A2 research.Involvement of cytokines and platelet-activating factor in renal pathology.Lipid mediators in inflammatory skin disorders.PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection.Leukotrienes and the immune system.Aspirin, platelets and prevention of vascular disease.Pathways in the biosynthesis of oxylipins in plants.Review: on the chemistry of oxidative stress.Extracellular phospholipase A2 expression and inflammation: the relationship with associated disease states.Interactions between sensory neuropeptides and lipid mediators in the airways.Secretory non-pancreatic group II phospholipase A2: role in physiologic and inflammatory processes.Sphingosine and sphingosine 1-phosphate in cellular proliferation: relationship with protein kinase C and phosphatidic acid.Phospholipase D-mediated hydrolysis of phosphatidylcholine: role in cell signalling.Cytosolic PLA2: mRNA levels and potential for transcriptional regulation.PAF-induced amplification of mediator release in septic shock: prevention or downregulation by PAF antagonists.Discovery of inhibitors of the 5-lipoxygenase activating protein (flap).Inflammation, prostaglandins, and loss of function.Pheromonal and reproductive function of F prostaglandins and their metabolites in teleost fish.Formation by the endothelium of prostacyclin, nitric oxide and endothelin.Diphenylmethylazine prostanoids with prostacyclin-like actions on human platelets.Thromboxane biosynthesis and metabolism in cardiovascular and renal disease.Prostaglandin D synthase is the key enzyme in the promotion of physiological sleep.Phospholipase A2 (PLA2) activity in gerbil brain: characterization of cytosolic and membrane-associated forms and effects of ischemia and reperfusion on enzymatic activity.
P1433
Q28257663-FD5EC5BB-CF29-4C0F-862C-69ABF048E3E4Q28263818-550B70F3-EE7D-4B33-A6CA-B1B7C7B58BA8Q28341773-205A2A49-5875-464F-80EB-DD70E172F8A3Q28341774-94BD2F9F-212D-4F65-9304-3B27E5CD51F6Q33376424-E6866DD7-31CF-44A3-B816-13211822AF39Q33385077-987487B5-BF96-4F5E-91A0-5D6F814E7F87Q33417557-27713584-B6B3-444D-B2B1-AE66D2132720Q33493829-7120FFC8-1859-4D7F-8C77-87133D2444FFQ33824050-104CAD77-3CCF-4A72-81F5-1866D144605BQ34816554-ED413F84-6A05-43D1-A4A8-EDE0FEEB467DQ35836278-7ACA2E91-C47B-4BF3-B929-23AA7B402FE9Q35836294-3CAE6C26-8C6E-43AA-AB3C-1A4554531C1AQ36440348-0AE9AD9A-13B0-4A7A-8637-5A35E9A94198Q37577289-08191A3D-2DF0-458D-82C1-A2C7BDF8589BQ37577294-A994D6B2-BA82-4439-9229-397E39D500DDQ37577310-7C6CB3A7-9145-4385-B8BD-7BF67F23A914Q37615955-DC5855B6-C25F-4F34-A816-868B83363129Q37844652-329FF752-A9FD-43E4-B608-5B3A19B8BAC1Q37844666-9961F3EA-48B9-4738-8D2A-8DD79F8E3D3CQ37847741-312F60BB-D47A-4249-9041-98C6B58752F7Q38246899-64642FAB-F5EB-4994-8B7B-441988759C63Q38246902-B08EF7FF-2196-460D-B651-06BDA17119C2Q38246904-B68AEEEC-93F8-4CBF-8823-4D61A1CC81AFQ40712056-6446E91F-8016-4F44-ADC7-31C08E778D52Q40770755-71D1B433-59B6-47FE-82BF-D688116D9537Q40788881-FB8835CB-27EF-4BF0-87F0-59DB407A2F58Q40794454-60250350-681C-4E73-9D59-FFB15FC6038DQ40794462-7D3DEF9C-0A52-4832-921E-35AAE75F6C7BQ40794468-7E3D1023-2B36-470D-B2D7-2307ED3ABC9BQ40794474-B5DD2A98-AE11-4476-AB9C-041855890606Q40794479-FA76FECC-09D3-4BBA-B101-EAB967C90924Q40838742-DD7DED17-76AA-4C73-95FB-17A5C1218DB7Q40838747-F04D9FE8-A2D8-476D-9DEB-3299EFB59183Q40838752-457B05D0-81E7-421E-9749-2CF38ADCB7BCQ40838758-3E077D9E-8295-44CC-90A2-3424649D9B14Q40838762-0609CFB1-EBB4-4CE4-A018-D8C6FFDD5A43Q40838765-A981B168-4B23-43F2-B5CA-38F9E3BE8D27Q40838768-379C0609-57B7-4934-A333-7F06588061CFQ40838780-252CBE13-4916-4302-AC87-B66B7CD02C0BQ40838785-3BC0C340-1922-4103-9D6F-B7174E56F436
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of lipid mediators
@ast
Journal of lipid mediators
@en
Journal of lipid mediators
@es
Journal of lipid mediators
@it
Journal of lipid mediators
@nl
type
label
Journal of lipid mediators
@ast
Journal of lipid mediators
@en
Journal of lipid mediators
@es
Journal of lipid mediators
@it
Journal of lipid mediators
@nl
altLabel
J Lipid Mediat
@en
prefLabel
Journal of lipid mediators
@ast
Journal of lipid mediators
@en
Journal of lipid mediators
@es
Journal of lipid mediators
@it
Journal of lipid mediators
@nl
P1055
P1156
P123
P1476
Journal of lipid mediators
@en